2 курс / Нормальная физиология / Ликвор_как_гуморальная_среда_организма_Пикалюк_В_С_,_Бессалова_Е

235.Тонких А.В. Гипоталамо–гипофизарная область и регуляция физиологических функций организма. –2 е изд. /

А.В. Тонких. – Л.: Наука, 1986. – 332 с.

236.Топало В.Г. Изменение физиологической активности цереброспинальной жидкости при нервных дистрофиях и влияние гетеро– и гомогенной цереброспинальной жидкости на трофическое

ифункциональное состояние органов и тканей: автореф. дис. канд.

мед. наук: 03.00.13./ В.Г. Топало. – М., 1986. – 223 с.

237.Тотолян А.А. Современные подходы к диагностике

А.В. Кузьмин, В.В. Эсаулова, Е.Л. Юндина // Вестник Российской ассоциации акушеров–гинекологов. – 1998. – № 3. – С. 49–52.

244.Функциональная межполушарная асимметрия: Хрестоматия / под общ. ред. акад. Н.Н. Боголепова, В.Ф. Фокина. –

М.: Научный мир, 2004. – 728 с.

245.Хавинсон В.Х. Пептидные биорегуляторы и старение / В.Х. Хавинсон, В.Н. Анисимов. – СПб.: Наука, 2003. – 223 с.

246.Харитонова Т.В. О некоторых механизмах изменения гуморального иммунитета у нейроонкологических больных в процессе

Р.И. Шендерова, В.В. Олейник, О.А. Якунова // Проблемы туберкулеза. – 2001. – № 5. – С. 22–24.

260. Шпрах В.В. Ликворосорбция в комплексной терапии тяжелых форм первичных гнойных менингитов / В.В. Шпрах, С.М. Горбачева, В.И. Горбачев //Неврологический журнал. –1997.

–№3. –С. 17-19.

261. Штерн Л.С. Непосредственная питательная среда органов

и тканей. Физиологические механизмы, определяющие ее состав и свойства / Л.С.КафедраШтерн. – М.: Изд–во АН СССР, 1960. – 551 с.

262. Штерн Л.С. Проблемы гистогематических барьеров/

Л.С. Штерн. – М.: Наука, 1965. – 331 с.

263. Шулев Ю.А. Применение ликворосорбции в нейрореанормальнойимат л гии / Ю.А. Шу ев, В.Н. Бикмуллин, А.А. Старче ко //VI Всероссийский съезд а естезиологов и

реаниматолог в. –М, 1998. –С.263.

264. Шульгин Г.Т. Влияние ксеногенной спинномозговой

– Симферополь, 1981. – 131 с.

жидкости наанатомиитече ие восст новительного пер ода после острой кровопотери: втореф. дис. к нд. мед. наук: 14.00.16/ Г.Т. Шульгин.

265. Щепиткин И.А. Фактор некроза опухоли как полипептидный фактор роста / И.А. Щепиткин // Успехи современной биологии.КГМУ– 1993. – Т. 113, № 5. – С. 617–625.

266. Эйнштейн Э. Белки мозга и спинномозговой жидкости в норме и патологии: Пер. с англ. / Э. Эйнштейн. – М.: Мир, 1988.

– 280 с.

267. Экспериментальное тестирование «дисфукцинов», извлеченных при ликворосорбции у больных с героиновой наркоманией / Н.А. Арсениев, Ю.Н. Бельских, В.Г. Шаляпина и соавт. // Эфферентная терапия. – 2000. – Т.3. – С.20-24.

268. Юренкова С.П. К вопросу об избирательности используемых сорбентов при экстракорпоральной очистке ликвора у нейрохирургических больных / С.П. Юренкова, Т.В. Харитонова // III съезд нейрохирургов России. –СПб, 2002. – С. 451-452.

269. Aberrated levels of cerebrospinal fluid chemokines in

Guillain–Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy / R. Press, M. Pashenkov, J.–P. Jin, H. Link // Journal of Clinical Immunology. – 2003. – Vol. 23, № 4. – Р. 259–267.

270.Abraham A.D. 3H–testosterone distribution and binding in rat thymus cells in vivo / A.D. Abraham, G. Bug // Mol Cell Biochem. – 1976. – Vol. 13. – P. 157–63.

271.Adguhr E. Ube rein zentrales Sinnesorgan bei den vertebraten

/E.Adguhr // Z. Anat. Entwgesch. – 1922. – Vol. 66. – P. 223–360.

272.Adinolfi A. Alfa–fetoprotein during development and in

desease / А. Adinolfi, М. Adinolfi, M.H.Lessof // J. Med. Genet. – 1975.

– Vol.12. – PКафедра. 138.

273. Akefeldt A. Cerebrospinal fluid neuropeptide Y in Prader– Willi syndrome / А. Akefeldt, R. Ekman, J.Mansson // Developmental Medicine & Child Neurology. – 2001. – Vol. 43, № 4. – Р. 286–287.

274нормальной. Alpha–melanocyte–stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease / L. Rainero, J.A. Kaye, C. May et al. // Arch. neurol. – 1988. – Vol. 45, № 11. – P. 1224–1227.

275. Analysisанатомииof tryptophan and tyrosine in cerebrospinal fluid by capillary electrophoresis and ''ball lens'' UV–pulsed laser–induced fluorescence detection / C. Bayle, N. Siri, V. Poinsot et al. // Journal of Chromatography A. – 2003. – Vol. 1013, № 1–2. – Р. 123–130.

276. Angelow S. Functional characterisation of the active ascorbic acid transport into cerebrospinalКГМУfluid using primary cultured choroid plexus cells / S. Angelow, М. Haselbach, Н.- J.Galla // Brain Research.

– 2003. – Vol. 988, № 1–2. – Р. 105–113.

277. Armstrong C. S. Uptake of circulating insulin–like growth factor–I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF–II mRNA content in diabetic rat brain / С. S. Armstrong, L. Wuarin , D.N. Ishii // J. Neurosci. Res. – 2000. – Vol. 59, № 5. – P. 649–660.

278. Arrenbrecht S. Specific binding of growth hormone to thymocyies / S. Arrenbrecht // Nature. – 1974. – Vol. 252. – P. 255–257.

279. Assies J. Protein hormones in the cerebrospinal fluid: Evidence for retrograde transport from the pituitary to the brain in man /

J.Assies, А. Schellekens, J.L. Touber // Clin. Endocr. – 1978. – Vol. 8, № 2. – P. 487–491.

280. Baehr C. Choroid plexus epithelial monolayers – a cell culture model from porcine brain / C. Baehr, V. Reichel, G. Fricker // Cerebrospinal Fluid Research. – 2006. – Vol. 3, №13. – P. 1–14.

281. Banks W.A. Selective, physiological transport of insulin across the blood–brain barrier: novel demonstration by species–specific radioimmunoassays / W.A. Banks, J.B. Jaspan, A.J. Kastin // Peptides. – 1997. – Vol. 18, №8. – P. 1257–1262.

282. Becher Burchard. Brain–immune connection: Immuno– regulatory propertiesКафедраof CNS–resident cells / Becher Burchard, Prat Alexandre, Р. Antel Jack // Glia. – 2000. – Vol. 29, № 4. – P. 293–304.

283. Bechter K. Cerebrospinal fluid filtration as experimental

Bethesda. – Maryland, 1998. –Р.123.

treatment in a case of Borna disease vims-encephalitis-related schizophreniaнормальной. 4th Symposium on the neurovirology and neuroimmunology of shizophrenia and bipolar disorder 5–7 november

284. Berciano J. Cerebrospinal fluid filtration for treating Guillain-

Barre syndromeанатомииis there any pathological background / Berciano J. // Anaesthesia. –2000. –Vol. 55, № 4. –Р. 408.

285. Bleier R. The relations of ependima to neurons and capillaries in the hypothalamus: a Golgi–cox study / R. Bleier // J. Comp. Neurol. – 1971. – Vol. 142, № 4. – P. 439–463.

286. Blood–brain barrierКГМУtransport of cationised immunoglobulin G: enchanced delivery compared to native protein / Triguero D., Buciac J.B., Yang J., Pardridge W.M. // Proc. Nat. Acad. Sci. USA – 1989. – Vol. 86, № 12. – P. 4761–4765.

287. Blood–brain, blood–cerebrospinal fluid and cerebrospinal fluid–brain barriers in a marsupial (macropus eugenii) during development / K. M. Dziegielewska, L. A. Hinds, K. Mollgard et al. // Journal of Physiology. – 1988. – Vol. 403. – P.367–388.

288. Bouchaud C. Serotoninergic innervations of ependimal cells in the rat subcomissural organ. A fluorescence electron microscopic and radioautographic study / С. Bouchaud, М. Arfuison // Biol. Cell. – 1977.

– Vol. 30, № 1. – P. 61–64.

166ЛИКВОР КАК ГУМОРАЛЬНАЯ СРЕДА ОРГАНИЗМА

289.Bradbury M.W.B. Transport of iron in the blood–brain– cerebrospinal fluid system / M.W.B. Bradbury // Journal of Neurochemistry. – 1997. – Vol. 69. – P. 443–454.

290.Brain–derived neurotrophic factor in cerebrospinal fluid of patients with chronic daily headache: relationship with nerve growth factor and glutamate levels / P. Sarchielli, A. Alberti, B. Gallai et al. // The Journal of Headache and Pain. – 2002. – Vol. 3. – Р. 129–135.

291.Bulat M. Biochemical communication of the brain and cerebrospinal fluid / М. Bulat // Periodicum Biologorum. – 1980. –

Vol.82. – P. 251–255

– Р. 90.

292. CakeКафедраM.H., Litwack G. The glucocorticoid receptors / М.Н. Cake, Litwack G. // Biochemical Actions of Hormones. – 1975. – Vol 3.

293. Caulaert van C. Sur la presence de l’hormone prehypophysaireнормальнойexcite–secretrice de la thyroide dans le sang et le liquid cephalorachidien et sur la repartition dans ces milieux / С. Caulaert van,

М. Aron, Stahl J. // Comp. Rend. Soc. Biol. – 1931. – Vol. 106. – P. 607–609.

294.Cerebrospinalанатомииfluid “pheresis” in Guillain-Barre syndrome / Wollinsky K.H., Hulser P.J., Westarp M.E. et al. //Med Hypoth. –1992. –Vol. 38. –Р. 155-165.

295.Cerebrospinal fluid adrenomedullin levels in patients with

pre–eclampsia / O. Celik, S. Hascalik, M. Yurekli, Y. Turkoz // Acta Obstetricia Et GynecologicaКГМУScandinavica. – 2003. – Vol. 82, № 6. – Р. 578–579.

296.Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells / M. Pashenkov, M. Soderstrom, Y.–M. Huang et al. // Clin Exp Immunol. – 2002. – Vol. 128. – P. 379–387.

297.Cerebrospinal fluid and plasma concentrations of POMC–related peptides in multiple sclerosis / L. Pinessi, I. Rainero, Т. de Gennaro et al. // Ann N Y Acad Sci. – 1992. – Vol. 650, № 7. –P. 351–354.

298.Cerebrospinal fluid and plasma concentrations of SRIH, beta– endorphin, CRH, NPY and GHRH in obese and normal weight subjects / A. Brunani, C. Invitti, A. Dubini et al. // J. Obes. Relat. Metab. Disord. – 1995. – Vol. 19, № 1. – P. 17–21.

299. Cerebrospinal fluid and plasma leptin measurements: covariability with dopamine and cortisol in fasting humans / M.M. Hagan, P.J. Havel, R.J. Seeley et al. // J. Clin. Endocrinol. Metab. – 1999. – Vol. 84, № 10. – P. 3579–3585.

300. Cerebrospinal fluid and serum protein levels of tumor necrosis factor–alpha (TNF–α), interleukin–6 (IL–6) and soluble interleukin–6 receptor (sIL–6R gp80) in multiply sclerosis patient / S.A. Vladic, G. Horvat, S. Vukadin et al. // Cytokine. – 2002. – Vol. 20, № 2. – Р. 86–89.

301. Cerebrospinal fluid concentrations of corticotropin–releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls:Кафедраresponse to amitriptyline treatment / I. Heuser, G. Bissette, M. Dettling et al. // Depress Anxiety. – 1998. – Vol. 8, № 2. – P. 71–79.

et al. // Arch. Gen. Psychiatry. – 1998. – Vol. 55, № 5. – P. 473–477.

302. Cerebrospinal fluid concentrations of somatostatin and biogenicнормальнойamines in grown primates reared by mothers exposed to manipulated foraging conditions / J.D. Coplan, R.C. Trost, M.J. Owens

303. Cerebrospinal fluid cytokines in AIDS dementia complex /О.

Perella, CarrieriанатомииP.B., Guarnaccia D., М. Soscia // J. Neurol. – 1992. – Vol. 239. – P. 387–388.

304. Cerebrospinal fluid filtration and immunoglobulins in multifocal motor neuropathy./ Finsterer J., Schwerer В., Bittner R.E., Mamoli B. // Clin Neuropathol. – 1999. – Vol 18, № 1. –Р. 31-36.

305. Cerebrospinal fluidКГМУfiltration in a case of schizophrenia related to “subclinical” Borna disease virus encephalitis / Bechter К., Herzog S., Schreiner V. et al. // Psychiatry, Psychoneuroimmunology, and Viruses / Ed. N. Muller. –Wien: Springer , 1999. –Р. 19-35.

306. Cerebrospinal fluid filtration in multiple sclerosis in patients as an experimental therapeutic approach / Haas J., Sailer M., Diizel E. et al. //J Neuroimmunol. – Suppl 1995. – Vol. 1. –Р.37.

307. Cerebrospinal fluid insulin–like growth factor–1, insulin growth factor binding protein–2 or nitric oxide are not increased in MS or ALST / С. Pirttila, S. Vanhatalo, U. Turpeinen, R. Riikonen // Acta Neurologica Scandinavica. – 2004. – Vol. 109, № 5. – Р. 337–341.

168ЛИКВОР КАК ГУМОРАЛЬНАЯ СРЕДА ОРГАНИЗМА

308.Cerebrospinal fluid levels of alpha–tocopherol in amyotrophic lateral sclerosis / F. De Bustos, F.J. Jimenez–Jimenez, J.A. Molina et al. // J. Neural. Transm. – 1998. – Vol. 105, № 6–7. – P. 703–708.

309.Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis / T. Ichiyama, H. Shoji, M. Kato et al. // European Journal of Pediatrics. – 2002. – Vol. 161, № 3. – Р. 133–137.

310.Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease / J.A. Molina, F.J. Jimenez–Jimenez, C. Vargas et al. // Acta

Neurologica Scandinavica. – 2002. – Vol. 106, № 6. – Р. 347–350.

Nadi, W.H. Theodore // Epilepsia. – 1993. – Vol. 34, № 2. – P. 255–261.

311. CerebrospinalКафедраfluid levels of neuropeptides, cortisol, and amino acids in patients with epilepsy / O. Devinsky, S. Emoto, N.S.

312. Cerebrospinal fluid levels of oxytocin in Prader–Willi syndrome:нормальнойa preliminary report / A. Martin, M. State, G.M. Anderson et al. // Biol. Psychiatry. – 1998. – Vol. 44, № 12. – P. 1349–1352.

313. Cerebrospinal fluid levels of thiamine in patients with

Alzheimer's disease / J.A. Molina, F.J. Jimenez–Jimenez, A. Hernanz et al. // Journalанатомииof Neural Transmission. – 2002. – Vol. 109, № 7–8. – Р. 1035–1044.

314. Cerebrospinal fluid levels of thiamine in patients with Parkinson's disease / F.J. Jimenez–Jimenez, J.A. Molina, A. Hernanz et al. // Neurosci Lett. –КГМУ1999. – Vol. 271, № 1. – P. 33–36.

315. Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis / C.A. Roca, T.P. Su, S. Elpern et al. // Biol. Psychiatry. – 1999. – Vol. 46, № 4. – P. 551–556.

316. Cerebrospinal fluid supports viability and proliferation of cortical cells in vitro, mirroring in vivo development / J.A. Miyan, M. Zendah, F. Mashayekhi et al.// Cerebrospinal Fluid Research. – 2006. – Vol. 3, №2. – P. 1–7.

317. Cerebrospinal fluid-filtration reduces TNF-alpha in bacterial meningitis CSF / Pfausler В., Grubwieser G., Bosch S. et al. // Eur J Neurol. –1995. –Vol. 2. –Р.570–572.

318. Changes in plasma LRH during the normal menstrual cycle in women / A. Miyake, J. Kawamurra, T. Aono, K. Kurachi // Acta endocr.

– 1980. – Vol. 93, № 3. – P. 257–263.

319.Changes with aging of steroidal levels in the cerebrospinal fluid of women / K. Murakami, Т. Nakagawa, M. Shozu et al. // Maturities. – 1999. – Vol. 33, № 1. – P. 71–80.

320.Cholinergic augmentation of lymphocyte–mediated cytotoxicity. A study of the cholinergic receptor of cytotoxic T lymphocytes / T.B. Strom, A.J. Sytkowkski, C.B. Carpenter et al. // Proc Natl Acad Sci USA. – 1974. – Vol. 71. – P. 1330–1333.

321.Chrousos G.P. The hypothalamic–pituitary–adrenal axis and immune–mediated inflammation / Chrousos G.P. // N Engl J Med. –

1995. – Vol. 332. – P. 1351–1362.

rats / K.E. Van Esseveldt, B.A. van der Geest, H. Duindam et al. // J.

322. CircadianКафедраrhythmicity of vasopressin levels in the cerebrospinal fluid of suprachiasmatic nucleus–lesioned and –grafted

Biol. Rhythms. – 1999. – Vol. 14, № 1. – P. 28–36. 323.нормальнойClemens J.A. Identification of prolactin in cerebrospinal fluid /

Clemens J.A., В. Sawyer // Exptl Brain Res. – 1974. – Vol. 21, № 4. – P. 399–402.

324. CNS immune privilege: hiding in plain sight / M.J. Carson, J..M. Doose, Bанатомии. Melchior et al. // Immunol Rev. – 2006. – Vol. 213. – P. 48–65.

325. Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia / H. Tohgi, Т. Abe, S. Takahashi et КГМУal. // Neurosci Lett. – 1992. – Vol. 141, № 1. – P. 9–12.

326. Concept and therapeutic effiency of CSF fltration in acute cases of Guillain-Barre syndrome / Wollinsky K.H., Hulser P.-J., Brinkmeier H. et al. // Symposium “CSF filtration – a new concept for the treatment of neurological diseases with autoimmune pathogenesis”. –Magdeburg, 1994. – Р. 142-144.

327. Continuous filtration of cerebrospinal fluid (CSF-Filtration) in fulminant bacterial meningitis / Kalischewski P., D. Schneider, Kьhn H.-J. et al. // A New adjuvant Therapeutic Strategy In Anesthesia, Pain, Intensive Care and Emergency Medicine, A. Gullo (eds). –Trieste, Foliazza Editore, 1996. –Р. 627-638.

328. Correlation between concentrations of calcitonin and parathyroid hormone in cerebrospinal fluid of man / S. Balabanov, V.

Tollner, H. Richter et al. // Acta endocrinol. – 1983. – Vol. 103, № 25. – P. 133–135.

329. Corticotropin–releasing factor (CRF) and interleukin–1 (IL–l) receptors in the brain–pituitary–immune axis / E.B. De Souza, E.L. Webster, D.E. Grigoriadis et al. // Psychopharmacol Bull. – 1989. – Vol. 25. – P. 299–305.

330. CSF insulin–like growth factor–1 in infantile neuronal ceroid lipofuscinosis / R. Riikonen, S.L. Vanhanen, J. Tynela et al. // Neurology. – 2000. – Vol. 54, № 9. – P. 1828–1832.

331. CSF monoamines, age and impulsivity in wild grivet monkeys (Cerco–pithecusКафедраaethiops) / L.A. Fairbanks, M.B. Fontenot, J.E. Phillips–Conroy et al. // Brain Behav Evol. – 1999. – Vol. 53, № 5 – 6. – P. 305–312.

332. Cushing H. Concerning the secretion of the infundibular lobe of theнормальнойpituitary body and its presence in the cerebrospinal fluid / Н. Cushing, Е. Goetsch // Am. J. Physiol. – 1910. – Vol. 27. – P. 60–86.

333. Dachel R. CSF filtration in the hronic inflammatory

demyelinating polyneuropathy / Dachel R., Knietsch A. //Symposium “CSF filtrationанатомии– a new concept for the treatment of neurological diseases with autoimmune pathogenesis”. – Magdeburg, 1994.

334. Davidsson P. Peptide mapping of proteins in cerebrospinal Јuid utilizing a rapid preparative two–dimensional electrophoretic procedure and matrixКГМУ–assisted laser desorption/ionization mass spectrometry / P. Davidsson, C.L. Nilsson // Biochimica et Biophysica Acta. – 1999. – Vol. 1473. – P. 391–399.

335. Davson H. The blood–brain barrier / H. Davson // J. Physiol. – 1976. – Vol. 255. – P. 1–28.

336. Dean A. Seehusen. Cerebrospinal fluid analisis / Dean A. Seehusen, Mark M. Reeves, Demitri A. Fomin // Am. Fam. Physician. – 2003. – Vol. 68. – P. 1103–1108.

337. Deane R. Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin–bound and free iron into the rat brain / R. Deane, W. Zheng, B.V. Zlokovic // Journal of Neurochemistry. – 2004. – Vol. 88. – P. 813–820.

338. Decreased cerebrospinal fluid levels of b–endorphin and ACTH in children with infantile spasms / S. Nagamitsu, T. Matsuishi, Y.